ImmuCell Corporation
ICCC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,157 | -$5,775 | -$2,494 | -$78 |
| Dep. & Amort. | $2,687 | $2,717 | $2,488 | $2,461 |
| Deferred Tax | $0 | $0 | $0 | $31 |
| Stock-Based Comp. | $326 | $369 | $266 | $144 |
| Change in WC | -$407 | -$2,269 | -$1,833 | -$1,623 |
| Other Non-Cash | -$92 | $261 | $29 | $19 |
| Operating Cash Flow | $358 | -$4,674 | -$1,544 | $954 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$466 | -$1,893 | -$3,975 | -$2,609 |
| Net Acquisitions | $0 | $0 | $11 | $15 |
| Inv. Purchases | $0 | $0 | $0 | -$15 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $996 |
| Other Inv. Act. | $5 | $2 | $11 | $15 |
| Investing Cash Flow | -$461 | -$1,890 | -$3,964 | -$1,597 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,468 | $1,814 | $1,103 | -$368 |
| Stock Issued | $4,356 | $0 | $30,670 | $4,233 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5 | -$63 | $11 | $14 |
| Financing Cash Flow | $2,883 | $1,751 | $1,114 | $3,879 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2,779 | -$4,813 | -$4,394 | $3,236 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $979 | $5,792 | $10,185 | $6,950 |
| End Cash | $3,758 | $979 | $5,792 | $10,185 |
| Free Cash Flow | -$108 | -$6,567 | -$5,519 | -$1,654 |